Dina Ben Yehuda

6.5k total citations
44 papers, 1.0k citations indexed

About

Dina Ben Yehuda is a scholar working on Pathology and Forensic Medicine, Oncology and Hematology. According to data from OpenAlex, Dina Ben Yehuda has authored 44 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pathology and Forensic Medicine, 15 papers in Oncology and 13 papers in Hematology. Recurrent topics in Dina Ben Yehuda's work include Lymphoma Diagnosis and Treatment (14 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Multiple Myeloma Research and Treatments (7 papers). Dina Ben Yehuda is often cited by papers focused on Lymphoma Diagnosis and Treatment (14 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Multiple Myeloma Research and Treatments (7 papers). Dina Ben Yehuda collaborates with scholars based in Israel, United States and Italy. Dina Ben Yehuda's co-authors include Aaron Polliack, Arnon Nagler, Amos Panet, Akram Alian, Yaqoub Ashhab, Izhar Hardan, Dror Meirow, Hila Raanani, Dor J and Ninette Amariglio and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Dina Ben Yehuda

44 papers receiving 981 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dina Ben Yehuda Israel	16	470	378	247	221	216	44	1.0k
Nathalie Douet‐Guilbert France	23	703 1.5×	401 1.1×	122 0.5×	147 0.7×	204 0.9×	109	1.8k
H. Behrendt Netherlands	24	325 0.7×	746 2.0×	259 1.0×	368 1.7×	72 0.3×	74	1.5k
Norio Wake Japan	20	364 0.8×	345 0.9×	207 0.8×	102 0.5×	160 0.7×	63	1.1k
Anne Perdrix France	15	290 0.6×	369 1.0×	199 0.8×	51 0.2×	436 2.0×	50	933
Jochen Casper Germany	13	241 0.5×	139 0.4×	145 0.6×	61 0.3×	33 0.2×	39	701
Ross S. Berkowitz United States	12	183 0.4×	118 0.3×	131 0.5×	64 0.3×	174 0.8×	17	627
Maria I. Zervou Greece	22	235 0.5×	51 0.1×	152 0.6×	89 0.4×	307 1.4×	88	1.3k
Inés Gómez‐Seguí Spain	11	178 0.4×	219 0.6×	56 0.2×	20 0.1×	95 0.4×	60	603
Jennifer T. Cronkhite United States	7	345 0.7×	153 0.4×	57 0.2×	46 0.2×	89 0.4×	7	1.8k
Kazuko Hamamoto Japan	17	435 0.9×	345 0.9×	138 0.6×	52 0.2×	14 0.1×	47	1.2k

Countries citing papers authored by Dina Ben Yehuda

Since Specialization

Citations

This map shows the geographic impact of Dina Ben Yehuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dina Ben Yehuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dina Ben Yehuda more than expected).

Fields of papers citing papers by Dina Ben Yehuda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dina Ben Yehuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dina Ben Yehuda. The network helps show where Dina Ben Yehuda may publish in the future.

Co-authorship network of co-authors of Dina Ben Yehuda

This figure shows the co-authorship network connecting the top 25 collaborators of Dina Ben Yehuda. A scholar is included among the top collaborators of Dina Ben Yehuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dina Ben Yehuda. Dina Ben Yehuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aumann, Shlomzion, Boaz Nachmias, Dina Ben Yehuda, et al.. (2023). Risk factors and outcomes of COVID‐19 in adult patients with hematological malignancies: A single‐center study showing lower than expected rates of hospitalization and mortality. European Journal Of Haematology. 111(1). 135–145. 1 indexed citations

Abd‐Elrahman, Ihab, et al.. (2020). Novel targeted mtLivin nanoparticles treatment for disseminated diffuse large B-cell lymphoma. Oncogene. 40(2). 334–344. 4 indexed citations

Pick, Marjorie, Vladimir Vainstein, Neta Goldschmidt, et al.. (2018). Daratumumab resistance is frequent in advanced‐stage multiple myeloma patients irrespective ofCD38 expression and is related to dismal prognosis. European Journal Of Haematology. 100(5). 494–501. 61 indexed citations

Kleinstern, Geffen, Riki Perlman, Ziad Abdeen, et al.. (2017). Ethnic variation in medical and lifestyle risk factors for B cell non-Hodgkin lymphoma: A case-control study among Israelis and Palestinians. PLoS ONE. 12(2). e0171709–e0171709. 15 indexed citations

Ganzel, Chezi, Ory Rouvio, Hila Magen, et al.. (2016). Primary Plasma Cell Leukemia Has a Poor Prognosis Even in the Era of Novel Agents - a Multicenter Case Series. Blood. 128(22). 5699–5699. 1 indexed citations

Tal, Yuval, et al.. (2016). Hypersensitivity Reactions to Rituximab: 53 Successful Desensitizations in 7 Patients with Severe, Near-Fatal Reactions. Journal of Allergy and Clinical Immunology. 137(2). AB39–AB39. 2 indexed citations

Damle, Rajendra N., Michael Schäffer, Shalini Chaturvedi, et al.. (2016). Early Changes in Circulating T-Cell Immune Profiles in Patients with Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Data from the Phase 3, Double-Blind HELIOS Trial. Blood. 128(22). 4397–4397. 2 indexed citations

Silverman, Jeffrey A., Walter E. Aulitzky, John Lister, et al.. (2010). Marqibo® (vincristine sulfate liposomes injection; VSLI) Optimizes the Dosing, Delivery, and Pharmacokinetic (PK) Profile of Vincristine Sulfate (VCR) In Adults with Relapsed and Refractory Acute Lymphoblastic Leukemia (ALL). Blood. 116(21). 2142–2142. 3 indexed citations

Meirow, Dror, Izhar Hardan, Dor J, et al.. (2008). Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients. Human Reproduction. 23(5). 1007–1013. 246 indexed citations

10.

Wolf, Dana G., Gail Amir, Batia Avni, et al.. (2007). Severe Epstein–Barr virus-associated hemophagocytic syndrome in six adult patients. Journal of Clinical Virology. 40(2). 156–159. 21 indexed citations

11.

Meirow, Dror, Micha Baum, Jacob Levron, et al.. (2007). Ovarian tissue cryopreservation in hematologic malignancy: Ten years' experience. Leukemia & lymphoma. 48(8). 1569–1576. 67 indexed citations

12.

Rund, Deborah, et al.. (2007). Plasma exchange as treatment for Lawsone (henna) intoxication. Journal of Clinical Apheresis. 22(4). 243–245. 7 indexed citations

13.

Spectre, Galia, Diana Libster, Sigal Grisariu, et al.. (2006). Bleeding, Obstruction, and Perforation in a Series of Patients With Aggressive Gastric Lymphoma Treated With Primary Chemotherapy. Annals of Surgical Oncology. 13(11). 1372–1378. 26 indexed citations

14.

Meirow, Dror, Jacob Levron, Talia Eldar‐Geva, Dina Ben Yehuda, & Dor J. (2005). Ovarian Tissue Storing for Fertility Preservation in Clinical Practice: Successful Pregnancy, Technology, and Risk Assessment. Fertility and Sterility. 84. S2–S2. 7 indexed citations

15.

Goldschmidt, Neta, Alexander Gural, & Dina Ben Yehuda. (2003). Extensive Splenic Infarction, Deep Vein Thrombosis and Pulmonary Emboli Complicating Induction Therapy with All-trans-retinoic Acid (ATRA) for Acute Promyelocytic Leukemia. Leukemia & lymphoma. 44(8). 1433–1437. 20 indexed citations

16.

Globerson, Amiela, Svetlana Krichevsky, Miriam Kidron, et al.. (2001). Ageing and the mismatch repair system. Mechanisms of Ageing and Development. 121(1-3). 173–179. 43 indexed citations

17.

Ashhab, Yaqoub, Akram Alian, Aaron Polliack, Amos Panet, & Dina Ben Yehuda. (2001). Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern. FEBS Letters. 495(1-2). 56–60. 147 indexed citations

18.

Meirow, Dror, Dina Ben Yehuda, M. Epstein, et al.. (1999). O-016. Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance, malformation rate, and genomic instability. Human Reproduction. 14(Suppl_3). 9–9. 1 indexed citations

19.

Abeliovich, Dvorah, Susana Ben‐Neriah, Rachel E. Cohen, et al.. (1999). Clinical Implications of Fluorescence In Situ Hybridization Analysis in 13 Chronic Myeloid Leukemia Cases. Cancer Genetics and Cytogenetics. 114(2). 100–107. 27 indexed citations

20.

Oren, Ran, et al.. (1991). Visceral Leishmaniasis: A Difficult Diagnosis and Unusual Causative Agent. The Journal of Infectious Diseases. 164(4). 746–749. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact